International Stem Cell (ISCO) Selling, General & Administrative (2010 - 2026)
International Stem Cell (ISCO) recorded Selling, General & Administrative of $1.06 million in Q2 2026, up 17.3% from $905,000 a year earlier.
International Stem Cell (ISCO) Selling, General & Administrative (2010 - 2026) Analysis & Trends
On a TTM basis, International Stem Cell's Selling, General & Administrative came in at $3.7 million as of Jun 30, 2026, up 5.2% year-over-year; for FY2025, it was $3.53 million, up 0.5% from FY2024.
- Annual Selling, General & Administrative has increased for three straight years, though with a five-year compound annual growth rate of -4.4% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $3.52 million in FY2024 (+0.1%), $3.51 million in FY2023 (+4.7%), $3.36 million in FY2022 (-17.8%) and $4.08 million in FY2021 (-7.6%).
- The Q2 2026 figure is the highest quarterly Selling, General & Administrative since Q3 2021.
- On a year-over-year basis, Selling, General & Administrative rose in three of the last seven quarters, with growth averaging 1.6%.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 17.3% in Q2 2026, against a decline of 28.7% in Q3 2022 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 3.41 Bn |
| 10 | International Stem Cell | 1.08 Mn | -2.89 Mn | 1.46 Mn | 1.06 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.06 Mn |
| Dec 31, 2025 | 946,000.00 |
| Sep 30, 2025 | 789,000.00 |
| Jun 30, 2025 | 905,000.00 |
| Mar 31, 2025 | 892,000.00 |
| Dec 31, 2024 | 907,000.00 |
| Sep 30, 2024 | 816,000.00 |
| Jun 30, 2024 | 884,000.00 |
| Mar 31, 2024 | 909,000.00 |
| Dec 31, 2023 | 964,000.00 |
| Sep 30, 2023 | 832,000.00 |
| Jun 30, 2023 | 918,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Dec 31, 2022 | 845,000.00 |
| Sep 30, 2022 | 808,000.00 |
| Jun 30, 2022 | 872,000.00 |
| Mar 31, 2022 | 832,000.00 |
| Dec 31, 2021 | 894,000.00 |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 1.01 Mn |
International Stem Cell Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ISCO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();